Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastroenteritis » Inflammatory Bowel Diseases » Crohn Disease
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Inflammatory Bowel Diseases » Crohn Disease
Description
A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. MeSH
Hierarchy View
Approved Indicated Drugs (15)
Phase 4 Indicated Drugs (63)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23)
Phase 2 Indicated Drugs (102)
allogeneic hematopoietic stem cells (Hemacord)
anti-interferon-gamma monoclonal antibody
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)
autologous cultured adipocytes
Phase 1 Indicated Drugs (25)
Other Experimental Indicated Drugs (26)
Organization Involved with Phase 4 Indications (120)
Atlanta Gastroenterology Associates
Australasian Gastro Intestinal Research Foundation (AGIRF)
Crohn's and Colitis Foundation
European Crohn´s and Colitis Organisation
Federal University of Juiz de Fora
Foundation for liver and gut studies
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (GETAID)
Health Research Board, Ireland
Hoosier Cancer Research Network
Hospital General Universitario Gregorio Marañon
Hospital S. Joao, Porto, Porpugal
Icahn School of Medicine at Mount Sinai
Institut National de la Santé Et de la Recherche Médicale, France
Moorgreen Hospital, Southampton
National Institute for Health Research, United Kingdom
People's Liberation Army of China
Schweizerische Morbus Crohnund Colitis ulcerosa Vereinigung
Shafran Gastroenterology Center
South-Eastern Norway Regional Health Authority
The Baruch Padeh Medical Center, Poriya
Organization Involved with Phase 3 Indications (106)
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
Canadian Institutes of Health Research (CIHR)
Centro di Riferimento Oncologico - Aviano
Children's Center for Digestive Healthcare, LLC, Atlanta, Georgia, USA
Children's Memorial Health Institute, Poland
Complexo Hospitalario Arquitecto Marcide
Complexo Hospitalario de Santiago
Ev. Krankenhaus Hattingen GmbH
Gastroenterology Research of America
Huazhong University of Science and Technology
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Katholieke Universiteit Leuven
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Royal Liverpool & Broadgreen University Hospitals NHS Truts
The Children's Memorial Institute
The Leona M. and Harry B. Helmsley Charitable Trust
Organization Involved with Phase 2 Indications (109)
Azienda Ospedaliera San Camillo Forlanini
Case Western Reserve University
Charlotte Gastroenterology & Hepatology, PLLC
International organization for the study of inflammatory bowel disease (IOIBD)
Massachusetts Institute of Technology
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
National College of Natural Medicine
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Research Agency, France
Oregon Health and Science University
Reistone Biopharma Company Limited
Santa Barbara Cottage Hospital
Organization Involved with Phase 1 Indications (20)
Organization Involved with Other Experimental Indications (34)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
